Țară: Irlanda
Limbă: engleză
Sursă: HPRA (Health Products Regulatory Authority)
PSEUDOEPHEDRINE HYDROCHLORIDE
The Boots Company Plc
R01BA; R01BA02
PSEUDOEPHEDRINE HYDROCHLORIDE
60 milligram(s)
Tablet
Product not subject to medical prescription
Sympathomimetics; pseudoephedrine
Marketed
2003-11-04
INFORMATION FOR THE USER Boots Pharmaceuticals Decongestant 60 mg Tablets Pseudoephedrine Hydrochloride READ ALL OF THIS LEAFLET CAREFULLY BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. This medicine is available without prescription to treat minor conditions. However, you still need to take it carefully to get the best results from it. Keep this leaflet, you may need to read it again Ask your pharmacist if you need more information or advice WHAT THIS MEDICINE IS FOR This medicine contains Pseudoephedrine Hydrochloride, a decongestant, which acts to relieve a blocked nose. It can be used to relieve the symptoms of a blocked nose and blocked sinuses to help you breathe more easily without causing drowsiness. BEFORE YOU TAKE THIS MEDICINE This medicine can be taken by adults and children of 12 years and over. However, some people should not take this medicine or should seek the advice of their pharmacist or doctor first. DO NOT TAKE: IF YOU ARE ALLERGIC to any of the ingredients (see “What is in this medicine”) IF YOU HAVE ANGINA or other heart or circulatory problems IF YOU HAVE HIGH BLOOD PRESSURE (including that due to a tumour near your kidney) IF YOU HAVE severe kidney disease IF YOU ARE TAKING MONOAMINE OXIDASE INHIBITORS (for depression) or have taken them within the last 14 days IF YOU ARE TAKING other medicines containing pseudoephedrine, or other decongestants TALK TO YOUR PHARMACIST OR DOCTOR: If you have diabetes, glaucoma or an overactive thyroid If you are a man with prostate problems If you develop a feverish generalised erythema associated with pustules, stop taking this medicine and contact your doctor or seek medical attention immediately. See section ‘Possible side effects’. Sudden abdominal pain or rectal bleeding may occur with Boots Decongestant 60 mg Tablets, due to inflammation of the colon (ischaemic colitis). Reduction of blood flow to your optic nerve may occur with Boots Decongestant 60 mg Tablets. If you develop sudden loss of vision, stop taking this medicine and contact y Citiți documentul complet
Health Products Regulatory Authority 09 September 2020 CRN009W44 Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Boots Pharmaceuticals Decongestant 60mg Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Active ingredient Pseudoephedrine hydrochloride 60 mg/tablet For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Tablet. Round white to off-white, flat-faced tablet with a bevelled edge. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For the symptomatic relief of nasal and sinus congestion. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION For oral administration. Adults and children over 12 years: One tablet if necessary, up to four times daily at intervals of not less than 4 hours. Children under 12 years: Not recommended. Elderly: There is no need for dosage reduction in the elderly. Renal dysfunction: Decongestant Tablets are contraindicated in patients with severe renal dysfunction. 4.3 CONTRAINDICATIONS Hypersensitivity to any of the ingredients. Avoid in patients with angina, coronary artery disease, severe hypertension, severe renal impairment and phaeochromocytoma. Should not be taken by patients being treated with monoamine oxidase inhibitors or within 14 days of stopping such treatment. Use in patients who are currently receiving other sympathomimetic drugs. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE Decongestant Tablets should be used with caution in patients with diabetes mellitus, angle closure glaucoma, hyperthyroidism and prostatic enlargement. This product should be used with great care in patients receiving phenothiazines or tricyclic antidepressants. Patients with prostatic hypertrophy may have increased difficulty with micturition. Health Products Regulatory Authority 09 September 2020 CRN009W44 Page 2 of 5 This product may act as a cerebral stimulant and give rise to insomnia, nervousness, hyperpyrexia, tremor and epileptiform convulsions. Severe Skin reactions Severe skin reactions such as acute generalized exanthematous pustulosis (AGEP) may oc Citiți documentul complet